Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 19, 1997

View Archived Issues

Annual Report: Peptech

MedImmune reports product sales increase 250% for Q4 1996

Cortex fiscal 1997 second-quarter and six-month results

Lidak announces first-quarter fiscal 1997 financial results

AEterna's 1996 financial results

Sugen continues to focus on TK inhibitors

Gliatech prepares H3 agonists

Antiproliferative agents from Pfizer

U.S. researchers prepare chloroquine analogues

Agents for BPH disclosed by Merck & Co.

SKB prepares cytokine inhibitors

University of California researchers report pseudopterosin derivatives

Antiarrhythmic agents from Merck & Co.

GRC-active agents from CoCensys modulate brain excitability

Another launch for SKB vaccine

Antiacne treatment available in the U.K.

First launch for lipid-lowering statin

Astra anesthetic/analgesic introduced in the U.K.

U.K. launch for P&U glaucoma Rx

New paclitaxel combination demonstrates enhanced efficacy

Efficacy of leukotriene antagonist in asthma

Role of bFGF in gastric ulcer healing

New ACAT inhibitor associated with diarrhea

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...